Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2005) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Reviews of Physiology Biochemistry and Pharmacology | journal | 5.545 Q1 | 70 | 10 | 40 | 2129 | 395 | 40 | 10.18 | 212.90 |  |
| 2 | Natural Product Reports | journal | 3.169 Q1 | 211 | 39 | 132 | 6176 | 988 | 128 | 6.70 | 158.36 |  |
| 3 | Studies in Natural Products Chemistry | book series | 0.419 Q3 | 49 | 50 | 83 | 6400 | 71 | 45 | 1.05 | 128.00 |  |
| 4 | Expert Opinion on Therapeutic Targets | journal | 0.999 Q1 | 106 | 89 | 169 | 10586 | 417 | 159 | 2.62 | 118.94 | |
| 5 | Expert Opinion on Emerging Drugs | journal | 0.570 Q2 | 54 | 53 | 88 | 6214 | 194 | 86 | 2.83 | 117.25 | |
| 6 | Current Drug Metabolism | journal | 1.926 Q1 | 122 | 42 | 120 | 4777 | 773 | 114 | 6.16 | 113.74 | |
| 7 | Handbook of Experimental Pharmacology | journal | 0.122 Q4 | 110 | 152 | 1 | 17170 | 0 | 1 | 0.00 | 112.96 | |
| 8 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.009 Q1 | 99 | 12 | 40 | 1342 | 143 | 39 | 3.47 | 111.83 | |
| 9 | Drug Design Reviews Online | journal | 11 | 48 | 0 | 5344 | 0 | 0 | 0.00 | 111.33 | | |
| 10 | Current Pharmacogenomics | journal | 0.224 Q3 | 12 | 24 | 32 | 2670 | 25 | 32 | 0.78 | 111.25 | |
| 11 | Medicinal Chemistry Reviews - Online | journal | 7 | 46 | 0 | 5102 | 0 | 0 | 0.00 | 110.91 | | |
| 12 | Critical Reviews in Toxicology | journal | 1.850 Q1 | 129 | 36 | 49 | 3985 | 298 | 47 | 5.45 | 110.69 | |
| 13 | Progress in Medicinal Chemistry | journal | 1.045 Q1 | 38 | 8 | 26 | 868 | 80 | 22 | 2.67 | 108.50 | |
| 14 | Current Drug Targets: Inflammation and Allergy | journal | 1.265 Q1 | 53 | 88 | 110 | 9313 | 358 | 106 | 2.74 | 105.83 | |
| 15 | Progress in Drug Research | book series | 1.063 Q1 | 46 | 23 | 39 | 2369 | 125 | 35 | 2.80 | 103.00 |  |
| 16 | Neurotherapeutics | journal | 0.712 Q2 | 136 | 58 | 51 | 5904 | 131 | 45 | 2.57 | 101.79 | |
| 17 | Expert Opinion on Drug Metabolism and Toxicology | journal | 100 | 51 | 0 | 5082 | 0 | 0 | 0.00 | 99.65 | | |
| 18 | American Journal of Drug Delivery | journal | 0.344 Q3 | 23 | 21 | 20 | 2033 | 16 | 20 | 0.80 | 96.81 | |
| 19 | Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents | journal | 11 | 64 | 36 | 5982 | 12 | 32 | 0.33 | 93.47 | | |
| 20 | Advanced Drug Delivery Reviews | journal | 2.713 Q1 | 366 | 145 | 336 | 13073 | 3197 | 286 | 7.73 | 90.16 | |
| 21 | Cellular and Molecular Life Sciences | journal | 2.691 Q1 | 261 | 271 | 707 | 24423 | 3766 | 702 | 4.94 | 90.12 | |
| 22 | BioDrugs | journal | 0.649 Q2 | 79 | 35 | 137 | 3137 | 357 | 133 | 2.30 | 89.63 | |
| 23 | Expert Opinion on Drug Delivery | journal | 0.372 Q2 | 133 | 81 | 16 | 7108 | 25 | 14 | 1.56 | 87.75 | |
| 24 | Expert Opinion on Biological Therapy | journal | 0.943 Q1 | 102 | 140 | 378 | 11936 | 1061 | 365 | 2.90 | 85.26 | |
| 25 | Expert Opinion on Investigational Drugs | journal | 1.059 Q1 | 117 | 137 | 423 | 11445 | 1588 | 412 | 3.61 | 83.54 | |
| 26 | Clinical Pharmacokinetics | journal | 1.745 Q1 | 184 | 86 | 248 | 6300 | 1723 | 245 | 7.12 | 73.26 | |
| 27 | Expert Review of Vaccines | journal | 0.801 Q2 | 105 | 82 | 240 | 5937 | 592 | 220 | 2.60 | 72.40 | |
| 28 | EMC - Toxicologie-Pathologie | journal | 0.101 Q4 | 6 | 14 | 16 | 996 | 0 | 15 | 0.00 | 71.14 |  |
| 29 | Drug Safety | journal | 1.053 Q1 | 140 | 86 | 272 | 5982 | 1158 | 258 | 4.11 | 69.56 | |
| 30 | Current Pharmaceutical Biotechnology | journal | 1.131 Q1 | 97 | 44 | 127 | 3041 | 408 | 114 | 2.78 | 69.11 | |
| 31 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 242 | 594 | 16676 | 1479 | 582 | 2.47 | 68.91 | |
| 32 | Particle and Fibre Toxicology | journal | 0.487 Q3 | 119 | 11 | 3 | 752 | 3 | 2 | 1.00 | 68.36 | |
| 33 | Molecular Diagnosis and Therapy | journal | 68 | 61 | 161 | 4159 | 452 | 159 | 2.90 | 68.18 | | |
| 34 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 50 | 155 | 3354 | 3 | 155 | 0.03 | 67.08 | |
| 35 | Toxicological Reviews | journal | 0.737 Q2 | 49 | 29 | 46 | 1862 | 109 | 45 | 2.37 | 64.21 | |
| 36 | Current Opinion in Investigational Drugs | journal | 0.921 Q2 | 83 | 148 | 571 | 8853 | 1617 | 531 | 3.06 | 59.82 | |
| 37 | Drugs of Today | journal | 0.517 Q2 | 57 | 76 | 243 | 4444 | 469 | 242 | 1.98 | 58.47 |  |
| 38 | Neuropsychopharmacology | journal | 2.583 Q1 | 249 | 238 | 727 | 13808 | 4232 | 688 | 5.53 | 58.02 | |
| 39 | Expert Opinion on Therapeutic Patents | journal | 0.550 Q2 | 88 | 120 | 374 | 6911 | 539 | 361 | 1.36 | 57.59 | |
| 40 | Journal of Liposome Research | journal | 0.478 Q2 | 64 | 15 | 73 | 852 | 127 | 70 | 1.05 | 56.80 | |
| 41 | Toxin Reviews | journal | 0.253 Q3 | 54 | 24 | 86 | 1359 | 64 | 77 | 0.74 | 56.63 | |
| 42 | Journal of Immune Based Therapies and Vaccines | journal | 1.060 Q1 | 21 | 7 | 14 | 365 | 29 | 13 | 2.07 | 52.14 | |
| 43 | Antiviral Chemistry and Chemotherapy | journal | 0.555 Q2 | 59 | 36 | 102 | 1871 | 190 | 101 | 2.01 | 51.97 | |
| 44 | Trends in Pharmacological Sciences | journal | 4.267 Q1 | 244 | 106 | 404 | 5469 | 3362 | 340 | 9.18 | 51.59 | |
| 45 | Journal of Molecular Medicine | journal | 2.335 Q1 | 157 | 116 | 305 | 5976 | 1366 | 283 | 4.65 | 51.52 | |
| 46 | Toxicology Mechanisms and Methods | journal | 0.175 Q4 | 55 | 46 | 108 | 2359 | 74 | 106 | 0.75 | 51.28 | |
| 47 | Psychopharmacology | journal | 1.898 Q1 | 214 | 461 | 1031 | 23539 | 4619 | 978 | 4.48 | 51.06 | |
| 48 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.258 Q3 | 56 | 70 | 281 | 3500 | 280 | 280 | 1.04 | 50.00 | |
| 49 | Apoptosis : an international journal on programmed cell death | journal | 2.324 Q1 | 128 | 132 | 209 | 6586 | 1084 | 207 | 4.93 | 49.89 | |
| 50 | Current Opinion in Molecular Therapeutics | journal | 1.121 Q1 | 67 | 82 | 268 | 4057 | 793 | 242 | 2.85 | 49.48 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data